In the BioHarmony Drug Report Database
Tekturna, Rasilez (aliskiren) is a small molecule pharmaceutical. Aliskiren was first approved as Tekturna on 2007-03-05. It is used to treat hypertension in the USA. It has been approved in Europe to treat hypertension. The pharmaceutical is active against renin. Tekturna’s patent is valid until 2026-02-19 (FDA).
Image (chem structure or protein)